Vestal Point Capital, LP Alx Oncology Holdings Inc Transaction History
Vestal Point Capital, LP
- $1.34 Trillion
- Q2 2024
A detailed history of Vestal Point Capital, LP transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Vestal Point Capital, LP holds 3,600,000 shares of ALXO stock, worth $6.05 Million. This represents 1.62% of its overall portfolio holdings.
Number of Shares
3,600,000
Previous 2,610,000
37.93%
Holding current value
$6.05 Million
Previous $29.1 Billion
25.41%
% of portfolio
1.62%
Previous 2.41%
Shares
3 transactions
Others Institutions Holding ALXO
# of Institutions
122Shares Held
40.8MCall Options Held
518KPut Options Held
142K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$16.3 Million33.06% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.22MShares$7.09 Million3.76% of portfolio
-
Redmile Group, LLC San Francisco, CA4.04MShares$6.78 Million1.59% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$4.52 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.18MShares$3.66 Million2.11% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $68.5M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...